The progressive study conducted by Fact.MR on the respiratory syncytial virus diagnostics market reveals underlying growth prospects edifying gross sales through 2031.
The progressive study conducted by Fact.MR on the respiratory syncytial virus (rsv) diagnostics market reveals underlying growth prospects edifying gross sales through 2031. It emphasizes on emerging sales pockets. In terms of taxonomy, the market has been segmented on the basis of Technology, End-Users.
Fact.MR, a market research and competitive intelligence provider,the global demand for respiratory syncytial virus (RSV) diagnostics is anticipated to progress positively, surging at a CAGR of above 9% across the 2021-2031 forecast period.
Growing demand for point of care testing of respiratory syncytial virus (RSV)-infected patients and developments in the field of specific markers such as proteomics and genomic are set to accelerate market growth over the coming years.
Increase in the number of patients suffering from RSV infections has raised the overall burden of the disease, and, as such, has fuelled demand for RSV diagnostics globally. Approval of respiratory syncytial virus diagnostic assays & kits is further opening up various opportunities for market players.
North America dominates the market for respiratory syncytial virus diagnostics due to advanced technologies and innovation across the region, while the market in Asia Pacific is expected to surge at a high growth rate over the forecast period due to increasing burden of RSV infections among the population.
Request a report sample to gain compressive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=6736
Key Takeaways from Market Study
- Market for respiratory syncytial virus diagnostics to grow 2.3X in value by 2031, and reach a valuation of US$ 1.3 Bn by 2031.
- RSV diagnostic kits & assays account for more one-third of the global market share.
- Market for RSV diagnostics in China to top US$ 253 Mn by 2031.
- Demand for respiratory syncytial virus diagnostics in Canada to increase at CAGR of 7.4%.
- Market in Japan anticipated to expand at CAGR of 6% from 2021 to 2031.
- New technological advancements in the field of diagnostics to boost market growth over next 10 years.
“Growing incidence of respiratory syncytial virus infections globally to boost demand for RSV diagnostics over coming years,” says a Fact.MR analyst.
Competitive Landscape
The respiratory syncytial virus diagnostics landscape is highly fragmented in nature. Manufacturers are focusing on technological innovations for speeding up the diagnosis of the respiratory syncytial virus.
- Abbott Laboratories
- Becton
- Dickinson and Company
- BioMérieux SA
- Bio-Rad Laboratories
- Coris BioConcept
- DiaSorin Molecular LLC (DiaSorin Inc)
- F. Hoffmann-La Roche AG
- Merck KgaA
- Quest Diagnostics Incorporated
- Quidel Corporation
- Thermo Fisher Scientific
To gain in-depth insights on Respiratory Syncytial Virus (RSV) Diagnostics Market, request methodology at
https://www.factmr.com/connectus/sample?flag=RM&rep_id=6736
Key Market Segments Covered in Respiratory Syncytial Virus Diagnostics Industry Research
·By Technology
- RSV Molecular Diagnostics
- RSV Monoclonal Antibodies
- Immunoassays
- Differential Light Scattering
- Artificial Intelligence
- Liposomes
- Flow Cytometry
- Chromatography
- Diagnostic Imaging
- Gel Microdroplets
·By End Users
- Respiratory Syncytial Virus Diagnostics at Hospitals
- Respiratory Syncytial Virus Diagnostics at Nursing Homes
- Respiratory Syncytial Virus Diagnostics at Commercial Laboratories
- Respiratory Syncytial Virus Diagnostics at Public Health Laboratories
Key Questions Answered in Fact.MR’s Respiratory Syncytial Virus (RSV) Diagnostics Market Report
- Which regions will continue to remain the most profitable regional markets for Respiratory Syncytial Virus (RSV) Diagnostics market players?
- Which factors will induce a change in demand for Respiratory Syncytial Virus (RSV) Diagnostics manufacturers during the assessment period?
- How will changing trends impact the Respiratory Syncytial Virus (RSV) Diagnostics market?
- How can market players capture the low-hanging opportunities in the Respiratory Syncytial Virus (RSV) Diagnostics market in developed regions?
- Which companies are leading the Respiratory Syncytial Virus (RSV) Diagnostics market?
- What are the winning strategies of stakeholders in the Respiratory Syncytial Virus (RSV) Diagnostics market to upscale their position in this landscape?
Explore Fact.MR’s Coverage on the Healthcare Domain –
Home Respiratory Therapy Market: The assistance and help provided by the respiratory therapist to people suffering from problems related to lung function and breathing as a part of respiratory care is respiratory therapy. Home respiratory therapy basically means the respiratory therapy is provided within the settings of an individual’s home.
Veterinary Respiratory Ventilators Market: Growing pet adoption and reimbursement in regions such as the U.S. and Europe are the major factors driving the growth of the global veterinary respiratory ventilators market. Technological advancements in veterinary respiratory ventilators are further driving the demand for the product in matured markets.
Respiratory Virus Vaccines Market: Incessantly rising demand in response to the unbridled spread of COVID-19 has pushed the respiratory virus vaccines market to the fore. Fact MR’s recent study on the market is intended to offer insights into the future and discover hidden opportunities for market players. Increasing R&D investments and initiatives are aiding exponential growth in the market.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000’s trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com